On Saturday Night January 22, 2011 our CME Group hosted a unique CME satellite symposium in conjunction with the jointly sponsored GI Cancers Symposium in San Francisco, California. At this event multidisciplinary community-based “tumor board” members presented cases that they collaborated on to a panel of GI cancer experts. To allow you to participate in an educational experience similar to the one presented during the event, we invite you to review the following case modules and provide your treatment recommendations. Once you vote, you will receive a graphic depiction of how the audience members would have treated the patient, what each of the faculty members would recommend and access to additional resources including the video proceedings of the case discussion.

Case 1: A 79-year-old man in good condition received prior adjuvant capecitabine for Stage T3N2M0 colon cancer after which an elevated CEA led to a CAT scan demonstrating an isolated peripheral lesion in the right lobe of the liver. PET shows no disease anywhere. Biopsy is compatible with colon cancer metastasis.

Case 2: A 79-year-old man in good condition received prior adjuvant capecitabine for Stage T3N2M0 colon cancer after which an elevated CEA led to a CAT scan demonstrating an isolated peripheral lesion in the right lobe of the liver. PET shows no disease anywhere. Biopsy is compatible with colon cancer metastasis.

Case 3: A 79-year-old man in good condition received prior adjuvant capecitabine for Stage T3N2M0 colon cancer after which an elevated CEA led to a CAT scan demonstrating an isolated peripheral lesion in the right lobe of the liver. PET shows no disease anywhere. Biopsy is compatible with colon cancer metastasis.

Case 4: A 79-year-old man in good condition received prior adjuvant capecitabine for Stage T3N2M0 colon cancer after which an elevated CEA led to a CAT scan demonstrating an isolated peripheral lesion in the right lobe of the liver. PET shows no disease anywhere. Biopsy is compatible with colon cancer metastasis.

Case 5: A 79-year-old man in good condition received prior adjuvant capecitabine for Stage T3N2M0 colon cancer after which an elevated CEA led to a CAT scan demonstrating an isolated peripheral lesion in the right lobe of the liver. PET shows no disease anywhere. Biopsy is compatible with colon cancer metastasis.

Case 6: A 79-year-old man in good condition received prior adjuvant capecitabine for Stage T3N2M0 colon cancer after which an elevated CEA led to a CAT scan demonstrating an isolated peripheral lesion in the right lobe of the liver. PET shows no disease anywhere. Biopsy is compatible with colon cancer metastasis.

Case 7: A 79-year-old man in good condition received prior adjuvant capecitabine for Stage T3N2M0 colon cancer after which an elevated CEA led to a CAT scan demonstrating an isolated peripheral lesion in the right lobe of the liver. PET shows no disease anywhere. Biopsy is compatible with colon cancer metastasis.

Case 8: A 79-year-old man in good condition received prior adjuvant capecitabine for Stage T3N2M0 colon cancer after which an elevated CEA led to a CAT scan demonstrating an isolated peripheral lesion in the right lobe of the liver. PET shows no disease anywhere. Biopsy is compatible with colon cancer metastasis.

Case 9: A 79-year-old man in good condition received prior adjuvant capecitabine for Stage T3N2M0 colon cancer after which an elevated CEA led to a CAT scan demonstrating an isolated peripheral lesion in the right lobe of the liver. PET shows no disease anywhere. Biopsy is compatible with colon cancer metastasis.

Case 10: A 79-year-old man in good condition received prior adjuvant capecitabine for Stage T3N2M0 colon cancer after which an elevated CEA led to a CAT scan demonstrating an isolated peripheral lesion in the right lobe of the liver. PET shows no disease anywhere. Biopsy is compatible with colon cancer metastasis.

Case 11: A 79-year-old man in good condition received prior adjuvant capecitabine for Stage T3N2M0 colon cancer after which an elevated CEA led to a CAT scan demonstrating an isolated peripheral lesion in the right lobe of the liver. PET shows no disease anywhere. Biopsy is compatible with colon cancer metastasis.

Case 12: A 79-year-old man in good condition received prior adjuvant capecitabine for Stage T3N2M0 colon cancer after which an elevated CEA led to a CAT scan demonstrating an isolated peripheral lesion in the right lobe of the liver. PET shows no disease anywhere. Biopsy is compatible with colon cancer metastasis.

Case 13: A 79-year-old man in good condition received prior adjuvant capecitabine for Stage T3N2M0 colon cancer after which an elevated CEA led to a CAT scan demonstrating an isolated peripheral lesion in the right lobe of the liver. PET shows no disease anywhere. Biopsy is compatible with colon cancer metastasis.